Role of microbubble ultrasound contrast agents in the non-invasive assessment of chronic hepatitis C-related liver disease

doi:10.3748/wjg.v12.i22.3461

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 22

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3839)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

321

HTML

2932

Figures (1-6)

344

Tables (1-1)

242

Sum=3839

Jun 14, 2006 (publication date) through Jan 12, 2025

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Jun 14, 2006; 12(22): 3461-3465
Published online Jun 14, 2006. doi: 10.3748/wjg.v12.i22.3461

Full Size Figure Download Figure

Figure 6 Graph showing hepatic vascular transit times (HVTT) in patients with mild hepatitis, moderate to severe hepatitis and established cirrhosis. There is progressive shortening of the HVTT with increasing severity of liver disease. Adapted from Lim et al[23].

Citation: Grier S, Lim AK, Patel N, Cobbold JF, Thomas HC, Cox IJ, Taylor-Robinson SD. Role of microbubble ultrasound contrast agents in the non-invasive assessment of chronic hepatitis C-related liver disease. World J Gastroenterol 2006; 12(22): 3461-3465
URL: https://www.wjgnet.com/1007-9327/full/v12/i22/3461.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i22.3461